Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism-based design of agents that selectively target drug-resistant glioma
Kingson Lin, Susan E. Gueble, Ranjini K. Sundaram, et al.
Science (2022) Vol. 377, Iss. 6605, pp. 502-511
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
Yun Chang, Xuechao Cai, Ramizah Syahirah, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 113
Signaling pathways in brain tumors and therapeutic interventions
Shenglan Li, Can Wang, Jinyi Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a/β-Catenin and Akt/NF-κB signaling pathways
Wanyu Wang, Xiaopeng Yuan, Jiasheng Mu, et al.
Phytomedicine (2023) Vol. 118, pp. 154933-154933
Closed Access | Times Cited: 27
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling
Xiao Liu, Qingdong Guo, Guangxun Gao, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma
Yufei Lan, Xiaodie Li, Boyang Liu, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101122-101122
Open Access | Times Cited: 14
Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors
Giulia Giacomini, Sandra Piquet, Odile Chevallier, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 5, pp. 2372-2388
Open Access | Times Cited: 13
Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy
Jianan Li, Jun Yang, Shaoping Jiang, et al.
Biomaterials (2024) Vol. 311, pp. 122708-122708
Closed Access | Times Cited: 13
The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer
Qingming Fang
Cancers (2024) Vol. 16, Iss. 2, pp. 331-331
Open Access | Times Cited: 12
DNA Adducts in Cancer Chemotherapy
Yupeng Li
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5113-5143
Closed Access | Times Cited: 11
Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
Timothy E. Richardson, Jamie M. Walker, Dolores Hambardzumyan, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 10
Microorganism microneedle micro-engine depth drug delivery
Bin Zheng, Qiuya Li, Laiping Fang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway
Yuheng Zou, Lanyang Xu, Wanyu Wang, et al.
Phytomedicine (2024) Vol. 129, pp. 155714-155714
Closed Access | Times Cited: 8
EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma
Eryan Yang, Biao Hong, Yunfei Wang, et al.
Cancer Letters (2024) Vol. 588, pp. 216812-216812
Closed Access | Times Cited: 7
Bacteria Synergized with PD‐1 Blockade Enhance Positive Feedback Loop of Cancer Cells‐M1 Macrophages‐T Cells in Glioma
Qi Chen, Yuyi Zheng, Xiaojie Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 20
Open Access | Times Cited: 7
Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment
Weiping Li, Xia Xu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
Advances in enzyme-free nucleic acid amplification-based fluorescent biosensors for real-time imaging of DNA repair enzymes in living cells
Qian Zhang, Cong Su, Jian‐Ge Qiu, et al.
Coordination Chemistry Reviews (2023) Vol. 496, pp. 215406-215406
Closed Access | Times Cited: 15
Expert opinion on translational research for advanced glioblastoma treatment
Xiaoteng Cui, Yunfei Wang, Junhu Zhou, et al.
Cancer Biology and Medicine (2023), pp. 1-9
Open Access | Times Cited: 13
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Rifaquat Rahman, Diana D. Shi, Zachary J. Reitman, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 5
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho, Jonatas Lobato Duarte, et al.
Materials Today Bio (2023) Vol. 20, pp. 100671-100671
Open Access | Times Cited: 12
Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy
Xue Yang, Zehao Cai, Ce Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Virtual Biopsy for the Prediction of MGMT Promoter Methylation in Gliomas: A Comprehensive Review of Radiomics and Deep Learning Approaches Applied to MRI
Augusto Leone, Veronica Di Napoli, Nicola Pio Fochi, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 251-251
Open Access
Therapeutic delivery – industry update covering October 2024
Iain Simpson
Therapeutic Delivery (2025), pp. 1-6
Closed Access
Polymersome-enabled brain Codelivery of STAT3 siRNA and CpG oligonucleotide boosts chemo-immunotherapy of malignant glioma
Songsong Zhao, Zhiwei Sun, Mingyu Xia, et al.
Journal of Controlled Release (2025), pp. 113764-113764
Closed Access
Integrative analysis reveals key molecular mechanisms and prognostic model for Ethylnitrosourea-induced gliomagenesis
Bo Tan, Tao Chen, Peng Song, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Exploiting Metabolic Defects in Glioma with Nanoparticle-Encapsulated NAMPT Inhibitors
Matthew A. Murray, Katelyn J. Noronha, Yazhe Wang, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 8, pp. 1176-1187
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top